Abstract-Acute aortic dissection (AAD) is associated with an inflammatory reaction, as evidenced by elevated inflammatory markers, including C-reactive protein (CRP). The association between the peak CRP level and long-term outcomes in type B AAD has not been systematically investigated. The purpose of this study was to investigate whether the peak CRP level during admission predicts long-term outcomes in type B AAD. We conducted a clinical follow-up study of type B AAD. We divided the study population into 4 groups according to the tertiles of peak CRP levels (T1: 0.60 to 9.37 mg/dL; T2: 9.61 to 14.87 mg/dL; T3: 14.90 to 32.60 mg/dL; and unavailable peak CRP group). Multivariate Cox regression analysis was applied to investigate whether the tertiles of peak CRP predict adverse events even after adjusting for other variables. A total of 232 type B AAD patients were included in this analysis. The median follow-up period was 50 months. CRP reached its peak on day 4.5Ϯ1.7. Mean peak CRP values in T1, T2, and T3 were 6.4Ϯ2. 
T ype B acute aortic dissection (AAD) is often successfully managed by medical therapy during the acute phase, with a lower in-hospital mortality rate compared with type A AAD. 1 However, the long-term prognosis of type B AAD is associated with both higher morbidity and mortality. [2] [3] [4] [5] In an attempt to identify high-risk patients, several predictors of longterm adverse events in type B AAD have been reported. 4,6 -9 These predictors include false lumen closure status and maximum aortic diameter, which can be evaluated using 2D imaging studies, such as computed tomography (CT). However, the anatomy of the dissection is often complex, making it difficult to estimate the severity of disease by 2D imaging markers alone.
AAD is associated with an inflammatory reaction, 10 -12 as evidenced by a significant elevation in inflammatory markers, including C-reactive protein (CRP). [13] [14] [15] [16] Although CRP levels during hospital admission show significant temporal variations, the peak CRP level has been reported to be a useful marker to estimate the whole severity of acute illness or to predict adverse events. 17, 18 However, the association between peak CRP and long-term outcomes in type B AAD has not been systematically investigated. Therefore, the purpose of this study was to investigate whether the peak CRP level predicts long-term outcomes in type B AAD.
Methods

Patients and Follow-Up
We identified type B AAD patients from hospital admission records between December 1989 and December 2008. The inclusion criteria were type B AAD presenting within 14 days of symptom onset and CT with contrast confirming a dissected descending aorta containing both a true and false lumen. The exclusion criteria were an in-hospital death in the index admission and loss to follow-up. Follow-up was performed via office visit, letter, or telephone contact. The day of the index discharge was determined as the beginning of follow-up. The study primary end points were all-cause death and aortic events, such as surgery of the thoracic aorta (ascending, arch, or descending), recurrence of an aortic dissection, and an aortic rupture. Because other follow-up studies in type B AAD had used all-cause mortality as the end point, we adopted all-cause mortality as the end point. 3, 9, 19, 20 However, we also collected information about the cause of each death, which allowed us to perform a secondary analysis using cardiovascular death and aortic events as the secondary end points. Patients were followed until meeting a study primary end point (death or an aortic event) or until the study end date (April 2009). Patients who did not experi-ence an outcome of interest were censored at the last known date of contact.
This study was performed in accordance with the Helsinki Declaration and was approved by the internal review board. All of the study patients had previously granted permission for use of their medical charts for research purposes.
Definition of Peak CRP
Circulating CRP was mostly measured daily or every other day until it reached its initial peak in our institution. Initial peak CRP level was defined as the peak CRP. From December 1989 to November 2003, CRP was measured by turbidimetric immunoassay (Iatron CRP-TIA, Iatron) using an autoanalyzer (JCA-RX20, JEOL Ltd). From November 2003 to December 2008, CRP was measured by latex agglutination nephelometry (NanopiaCRP, Sekisui Medical) using an autoanalyzer (JCA-BM2250, JEOL Ltd). When the admission or predischarge CRP level was higher than the rest of the CRP levels, we were unable to determine the peak CRP level. We divided the patients who had peak CRP levels into 3 groups according to the tertiles of peak CRP, with T1 being the lowest and T3 being the highest (CRP level; T1: 0.60 to 9.37 mg/dL; T2: 9.61 to 14.87 mg/dL; T3: 14.90 to 32.60 mg/dL). The patients who did not have peak CRP levels were included in an unavailable peak CRP group (UG). The initial CRP level, which was measured after admission, was defined as the initial CRP.
Definition of Other Clinical Criteria
Clinical criteria were defined as described here. Hypertension was defined as systolic blood pressure Ͼ140 mm Hg, diastolic blood pressure Ͼ90 mm Hg, or medical treatment for hypertension before admission. Hyperlipidemia was total cholesterol level Ͼ220 mg/dL, low-density lipoprotein cholesterol level Ͼ140 mg/dL, or treatment for hyperlipidemia before admission. Diabetes mellitus was hemoglobin A1c level Ͼ6.5% or treatment for diabetes mellitus before admission. Estimated glomerular filtration rate was calculated from the serum creatinine level, age, weight, and sex, according to the Cockroft-Gault formula, 21 and estimated glomerular filtration rate Յ60 mL/min was considered impaired renal function. CT scan with intravenous contrast was performed Ն1 time in all of the patients. The initial examination was used for the statistical analysis. Partial enhancement of the false lumen was defined as a nonthrombosed type, and an intramural hematoma of the aorta was included as a thrombosed type. Maximum aortic diameter of the dissected aorta was also measured in all of the patients.
Statistical Analysis
Data are presented as frequencies and percentages for categorical variables and meanϮSD for continuous variables. Patient characteristics are compared between the groups divided by the tertiles of peak CRP. Parametrical data were compared using a 1-way ANOVA, whereas nonparametrical data were compared using the Kruskal-Wallis test. Categorical data were compared using the 2 test. The Kaplan-Meier curves stratified according to the tertiles of peak CRP were constructed. Multivariate Cox regression analysis was applied to investigate whether the tertiles of peak CRP predict adverse events even after adjusting for other variables using 3 models. In model 1, we selected independent variables by a statistical selection. We used significantly different characteristics among the 4 groups as the independent variables. In model 2, we selected independent variables by a clinical selection. We adopted known factors such as age, sex, maximum aortic diameter, false lumen closure status, the extent of dissection, statin use, antihypertensive medications at discharge, and impaired renal function as independent variables. 3,4,6 -9,22 The difference between CRP measurements was also adopted in this model. In model 3, we selected independent variables by a combination of statistical selection and clinical selection. We adopted all of the independent variables used in model 1 and model 2. All of the variables were simultaneously adjusted in 1 step. Hazard ratios (HRs) and the 95% CI were calculated. We constructed a conventional receiver operating characteristic curve to analyze peak CRP levels to determine the cutoff points that yielded the highest combined sensitivity and specificity with respect to distinguishing patients with adverse events from those without such events. A PϽ0.05 was considered statistically significant. All of the analyses were performed using statistical software, SPSS 13.0/Windows (SPSS Inc).
Results
Between December 1989 and December 2008, there were 263 patients with type B AAD admitted to Saitama Medical Center. Ten patients were excluded from the study because of the lack of critical information, such as a CT. Nine patients died during the index admission. Twelve patients were lost to follow-up. Thus, a total of 232 type B AAD patients were included in this analysis. The median follow-up for the 232 patients was 50 months. Although peak CRP levels were available in 200 patients, peak CRP levels were unavailable in 32 patients (admission CRP levels higher than the rest of the CRP levels [nϭ22]; predischarge CRP levels higher than the rest of the CRP levels [nϭ8]; serial measurements of CRP data not obtained [nϭ2]). The 200 patients who had peak CRP levels were divided into 3 groups according to the tertiles of peak CRP, with T1 being the lowest and T3 being the highest. The 32 patients who did not have peak CRP levels were included in a UG. A patient flowchart is shown in Figure S1 (available in the online Data Supplement at http://hyper.ahajournals.org).
In 88% of the patients who had an available peak CRP (176 of 200), CRP reached its peak between day 3 and day 6 (day: 4.5Ϯ1.7). The correlation coefficient between initial CRP levels and peak CRP levels was 0.23 (Spearman rank coefficient: Pϭ0.001). The clinical characteristics among all, T1, T2, T3, and UG are shown in Table 1 . Mean peak CRP values in the total population, T1, T2, and T3 groups were 12.6Ϯ6.1, 6.4Ϯ2.4, 12.0Ϯ1.5, and 19.5Ϯ4.0 mg/dL, respectively. Initial CRP levels, time from onset to admission, being overweight (body mass index Ͼ25 kg/m 2 ), current smoking, impaired renal function at admission, white blood cell counts, heart rate at discharge, and diuretics as an antihypertensive medication at discharge were significantly different among groups. The Kaplan-Meier curves stratified according to the tertiles of peak CRP and unavailable peak CRP are shown in the Figure. Log-rank testing revealed a significant increase in adverse events in the T3 group and UG as compared with the T1 group (Pϭ0.0001 for T3 versus T1; Pϭ0.0004 for UG versus T1). There were 65 events (39 deaths and 26 aortic events) during the follow-up period (Table S1) .
Multivariate Cox regression analysis was performed in 3 ways. In model 1, the tertiles of peak CRP and significant confounding factors, such as tertiles of initial CRP, time from onset to admission, being overweight, current smoking, impaired renal function at admission, white blood cell counts, heart rate at discharge, and diuretics as antihypertensive medication at discharge, were adopted as independent variables (Table 2) . UG, T3, and T2 (versus T1) were strong predictors of adverse events (UG: HR: 7.07 [95% CI: 2.60 to Figure.
Kaplan-Meier curve stratified according to the tertiles of peak CRP. The P value was calculated by the log-rank test. We constructed receiver operating characteristic curves and calculated statistics for the area under the curve. The area under the curve was 0.60 (95% CI: 0.51 to 0.69; Pϭ0.03). A peak CRP value of 9.5 mg/dL, which is the cutoff value between T1 and T2, has a 76% sensitivity and a 37% specificity for the occurrence of adverse events. A peak CRP value of 14.9 mg/dL, which is the cutoff value between T2 and T3, has a 46% sensitivity and a 71% specificity for the occurrence of adverse events.
Because the timeline of the study is fairly long, the time effect might affect patient outcomes. To investigate the time effect, we divided the 232-patient study group in half and compared outcomes between the former 116 patients (from December 1989 to November 2002) and the latter 116 patients (from November 2002 to December 2008) by logrank test. Event-free survival at 3 years was not different (91% in former patients versus 88% in latter patients; Pϭ0.12). The prescription rate of calcium channel blockers, ␤-blockers, ␣-blockers, and diuretics at discharge was not significantly different between the former and the latter patients. Although the prescription rate of angiotensinconverting enzyme inhibitors was higher in the former patients (39.7% versus 17.2%; Pϭ0.0002), that of angiotensin receptor blocker was higher in the latter patients (11.2% versus 40.5%; PϽ0.0001).
Discussion
We investigated whether the peak CRP level has any prognostic value in predicting long-term outcomes in 232 type B AAD patients. Although initial CRP levels were not associated with adverse events, peak CPR levels were significantly associated with adverse events. Peak CRP levels were a better marker than initial CRP levels in the risk stratification of type B AAD patients. Because it takes several days to reach a peak CRP, initial CRP levels might not reflect the whole severity of aortic dissection. Our results showed that the peak CRP level was a strong predictor of long-term outcomes in type B AAD.
Although type A AAD is a life-threatening disease and needs emergent surgery, type B AAD is considered to be a relatively benign condition, with few cases requiring emer- ACE indicates angiotensin-converting enzyme; CCB, calcium channel blocker; eGFR, estimated glomerular filtration rate. In this model, age, sex, the difference of CRP measurements, and previously reported risk factors, such as maximum aorta diameter, nonthrombosed type, the extent of dissection, impaired renal function, statins, and antihypertensive medications are adopted as independent variables. All of the variables are adjusted in 1 step. ACE indicates angiotensin-converting enzyme; CCB, calcium channel blocker; eGFR, estimated glomerular filtration rate. In this model, all of the variables used in model 1 and model 2 are adopted as independent variables. All of the variables are adjusted in 1 step. gent surgery during hospital admission. However, long-term outcomes of type B AAD are not necessarily better than that of type A AAD. 2, 3 Type B AAD is associated with a high mortality rate (Ϸ20% at 3 years 3 ) and a high morbidity rate (Ϸ30% morbidity at 2 years) in the long term. 4, 5 Therefore, identifying high-risk patients is of special clinical importance.
Earlier studies have identified long-term predictors of morbidity and mortality in type B AAD, including female sex, a history of previous aortic aneurysm, a history of atherosclerosis, and impaired renal function. 3, 19, 20, 22 In particular, multiple groups have reported that the maximum aortic diameter (Ն40 mm) and false lumen closure status are long-term predictors in type B AAD. 4,6 -9 Some of these predictors, including sex, history of previous aneurysm, and history of atherosclerosis, may be more representative of a patient's high-risk clinical background rather than the nature of the aortic dissection itself. On the other hand, false lumen closure status and the maximum aortic diameter may represent the nature of the aortic dissection for each individual patient. These parameters are relatively simply derived from 2D CT. False lumen closure status is generally classified as 1 of 2 patterns (thrombosed and nonthrombosed) or 3 patterns (thrombosed, nonthrombosed, and partially thrombosed). 4, 6, 8, 9 Maximum aortic diameter is calculated from 1 cross-sectional image. 4, 6, 8 However, the anatomy of the aortic dissection is often complex and is not necessarily consistent, even during the initial hospital stay. [23] [24] [25] It may be difficult to estimate the whole nature of the AAD by these simple imaging parameters alone.
The possible explanation for why an elevated peak CRP level was associated with long-term adverse events may be several fold. In general, the peak CRP level is an excellent marker for the severity of a variety of acute illnesses. For instance, an elevated peak CRP level during hospitalization for an acute myocardial infarction has been reported to be an independent predictor of cardiac rupture, left ventricular aneurysmal formation, 1-year cardiac death, and left ventricular remodeling. 17, 18, 26, 27 Peak CRPs in acute myocardial infarction might reflect the myocardial damage and severity of myocardial infarction itself in the acute phase. In our study, peak CRP levels are presumably reflective of the severity of AAD in the acute phase. Our results also suggest the possibility that the severity expressed by the peak CRP has a lasting impact on long-term clinical events.
Another possible explanation is that the peak CRP may represent the extent of the inflammatory reaction in the dissected aortic wall and may also reflect the damage to the lesion. Recent studies have revealed the close relationship between local inflammation in the aortic wall and the aortic dissection. 10, 12, 28 Kuehl et al 10 have demonstrated the association of inflammation with aortic dissection using positron emission tomography. He et al 28 have immunopathologically demonstrated that T lymphocytes and macrophages are common features in medial degeneration in the aortic dissection. These studies suggest that inflammation is present in the dissected aortic wall. The severely damaged aortic wall may more easily expand, may be more prone to redissection, and may be at higher risk of rupture during the chronic phase versus a less severely damaged aortic wall.
The major part of CRP is synthesized by hepatocytes, driven by interleukin 6 with synergistic enhancement of interleukin 1 or tumor necrosis factor. 29, 30 CRP can also be produced locally in atherosclerotic lesions. 31 Although CRP is generally considered to be an inflammatory marker or an atherosclerotic marker, [32] [33] [34] CRP also plays a role as a mediator of atherosclerosis. CRP directly influences several phases of atherosclerosis via complement activation, apoptosis, vascular cell activation, monocyte recruitment, lipid accumulation, and thrombosis. 31, 35 Therefore, exaggerated CRP itself might exert harmful effects that promote the atherosclerosis of the dissected aortic wall.
Of the 232 study patients, there were 32 patients whose peak CRP was unavailable. Interestingly, the outcomes of these patients were comparable to the highest tertile of the peak CRP group. One possible explanation is the difference in "time from onset to admission." The mean time from onset to admission in these 32 patients was 4.7Ϯ4.3 days, which was longer than the other 3 groups. Some of these patients might not have received adequate medical therapy, such as aggressive blood pressure lowering in the days after the onset of dissection. Another possible explanation is a selection bias before admission to our medical center. Because our medical center is a tertiary referral hospital, patients who had developed complications over the course of several days may have subsequently been referred to our hospital.
Peak CRP as a long-term predictor has several advantages over other predictors. First, the predictive power is potent with a high HR (3.99 to 6.02 adjusted for all of the confounders) in the highest tertile of peak CRP levels. Even the middle tertile of peak CRP has a moderate HR (2.42 to 3.25). In addition, CRP is a relatively simple marker widely available for clinical use.
Study Limitations
Although our study population is fairly large and the follow-up period is relatively long, this single-center retrospective study design poses a risk for patient selection bias. Because the timeline of the study period is fairly long, the change in the standard of care might have been a confounder of this study. Because CRP is a nonspecific inflammatory marker, it reflects not only the aortic dissection itself but also secondary processes, such as pneumonia. In addition, initial management, such as blood pressure control or pain control, might also affect the CRP. Although the CRP level was measured daily or every other day in most patients, it was measured less frequently in some patients. The methods to measure CRP have also changed from turbidimetric immunoassay to latex agglutination nephelometry during the study period. Although these 2 methods have been reported to be highly associated (rϭ0.9916; mean difference 0.19 mg/L; limits of agreement: Ϫ0.36 to 0.74 mg/L), 36 latex agglutination nephelometry was a more accurate method. However, the accuracy of the latex agglutination nephelometry is more important in detecting chronic inflammation in the general population and does not have as much significance during acute illness, whereas CRP levels are naturally much higher. Therefore, we do not think that changing the method of CRP measurement would have a significant effect on our results. Because the time from onset to admission was different in each patient, the time from onset to initial CRP measurement after admission was also different in each patient. This time difference might limit the value of initial CRP. Our main diagnostic tool for the AAD has been CT with contrast. Therefore, it is often difficult to differentiate intramural hematoma from thrombosed type AAD. In addition, we could not evaluate the presence of rapid aortic expansion as a study end point, because each interval between follow-up CT analyses was not consistent. However, our institution recommended elective surgery to patients who had rapid aortic expansion. Therefore, it is possible that we were able to capture rapid aortic expansion in a portion of patients. Finally, because the surgeons had access to laboratory values reflecting an increased inflammatory status during the index admission, there is a possibility that such information affected their decision to operate during long-term follow-up.
Perspectives
In our retrospective study, the peak CRP is a strong predictor for adverse long-term events in patients with type B AAD, but this should be validated by a prospective study. Peak CRP would be a better prognostic marker than an initial CRP. Obtaining an initial CRP level at 1 time point might be insufficient to identify high-risk patients. Our results may support the effort to find a peak CRP level for the risk stratification of type B AAD. Careful clinical follow-up may be warranted in those patients who have a high peak CRP during their index admission.
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